{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT03746431: Phase 1/Phase 2 Interventional Recruiting Advanced Solid Tumours
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01846481: Phase 2 Interventional Completed Opioid Dependence
(2013)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02760225: Not Applicable Interventional Completed Melanoma
(2016)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT00523159: Phase 2 Interventional Completed Renal Cell Carcinoma
(2007)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:iodine (¹²⁴I) evuzamitide [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00914914: Phase 1 Interventional Completed Refractory Solid Tumors
(2009)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04028063: Phase 2 Interventional Recruiting Metastatic Soft Tissue Sarcoma
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00523159: Phase 2 Interventional Completed Renal Cell Carcinoma
(2007)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
